Ellevest Inc’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,994
Closed -$46.9K 1220
2023
Q1
$46.9K Buy
1,994
+951
+91% +$25.5K ﹤0.01% 619
2022
Q4
$29.1K Sell
1,043
-102
-9% -$2.61K ﹤0.01% 750
2022
Q3
$27K Buy
1,145
+867
+312% +$26.2K ﹤0.01% 741
2022
Q2
$9K Sell
278
-333
-55% -$11.7K ﹤0.01% 910
2022
Q1
$21K Buy
611
+44
+8% +$1.5K ﹤0.01% 736
2021
Q4
$17K Sell
567
-45
-7% -$1.47K ﹤0.01% 743
2021
Q3
$20K Buy
+612
New +$19.6K ﹤0.01% 666

Other funds holding OGN

Ellevest Inc's OGN Position: Q2 2023 in Review

Ellevest Inc sold out of Organon & Co (OGN) in Q2 2023, closing a stake of 1,994 shares — an estimated $46.9K sold.

Ellevest Inc first reported a position in OGN in Q3 2021 and held it in 7 quarters. The position peaked at $46.9K in Q1 2023. 726 funds tracked by Wall St. Rank hold OGN as of Q2 2023.

  • Ellevest Inc reported no remaining Organon & Co position as of Q2 2023 after selling out during the quarter.
  • Ellevest Inc sold 1,994 Organon & Co shares in Q2 2023, an estimated $46.9K.
  • Ellevest Inc first reported a position in Organon & Co in Q3 2021 and held it in 7 quarters.
  • Ellevest Inc's Organon & Co position peaked at $46.9K in Q1 2023.
  • 726 funds tracked by Wall St. Rank held Organon & Co as of Q2 2023.

Based on Ellevest Inc's 13F filing for Q2 2023, filed 9 Aug 2023.